Clinical trial Recruiting at 14 sites Observational

Evaluating healthcare quality in semi-intensive care units

Official title: Evaluation and Improvement of the Health-care Quality in Semi-intensive Care Units

Run by Mario Negri Institute for Pharmacological Research · NCT04676347 · Data updated 2026-11-12

This study is trying to see how well semi-intensive care units are providing care by collecting data from patients and hospitals over five years.

Quick facts

Study typeObservational
SexAll
Enrollment39000 (estimated)
SponsorMario Negri Institute for Pharmacological Research
Academic / other
Locations18 sites (Milan, Milan and 17 other locations)
StatusRecruiting
StartedJuly 1, 2021
Main results expectedDecember 1, 2022
Study endsDecember 2029
Registry record updatedMay 20, 2026
Trial IDNCT04676347 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are all patients hospitalized in semi-intensive care units.

Probably not a fit

Patients who are not hospitalized in semi-intensive care units will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a continuous evaluation system for healthcare quality in semi-intensive care units. It involves collecting data from patients and structural information from hospitals to create quality indicators. By analyzing these indicators, the study will assess the overall level of care provided in each semi-intensive care unit. The study will last for five years, with annual reports to evaluate the results of each unit.

Why it matters

Potential benefit: If successful, this study could lead to improved healthcare quality and patient outcomes in semi-intensive care units.

How similar studies have gone: Other studies focusing on quality evaluation in healthcare settings have shown success, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* all patients hospitalised in a semi-intensive care unit

Exclusion Criteria:

* None

Where it's running

  • ASO SS Antonio e Biagio e Cesare Arrigo
    Alessandria, Italy
    Recruiting
  • Ospedale San Bassiano
    Bassano del Grappa, Italy
    Recruiting
  • Ospedale Maggiore
    Bologna, Italy
    Recruiting
  • AOU Policlinico S. Marco
    Catania, Italy
    Recruiting
  • Ospedale Bufalini
    Cesena, Italy
    Recruiting
  • Ospedale Santa Maria delle Grazie
    Naples, Italy
    Recruiting
Show 12 more locations
  • AOU San Luigi Gonzaga
    Orbassano, Italy
    Recruiting
  • AOU Padova
    Padova, Italy
    Recruiting
  • Ospedale E.Agnelli
    Pinerolo, Italy
    Recruiting
  • Ospedale degli Infermi
    Rivoli, Italy
    Recruiting
  • Ospedale Sant'Eugenio
    Roma, Italy
    Recruiting
  • AOU di Sassari
    Sassari, Italy
    Recruiting
  • Ospedale Giovanni Bosco
    Torino, Italy
    Recruiting
  • Ospedale Michele e Pietro Ferrero
    Verduno, Italy
    Recruiting
  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS
    Milan, Milan, Italy
    Active not recruiting
  • Ospedali Riuniti
    Livorno, Italy
    Not yet recruiting
  • ASST Lodi
    Lodi, Italy
    Not yet recruiting
  • Ospedale Ca' Foncello
    Treviso, Italy
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • See if the ED admission decisions are appropriate

    This study tests whether the decision to admit patients from the emergency department is appropriate for adults who come in with symptoms like chest pain, shortness of breath, fainting, or abdominal pain.

    Recruiting Mario Negri Institute for Pharmacological Research · Alessandria and 6 other locations · NCT06846879

  • Evaluating targeted therapy effectiveness in advanced lung cancer using RecistTM criteria

    This study is testing if a new way to measure how well targeted therapy works can help people with advanced lung cancer who have specific gene changes.

    Recruiting Third Military Medical University · Chongqing, Chongqing Municipality · NCT06142058

  • Brain tissue bank for traumatic brain injury patients undergoing contusion removal

    This study collects brain tissue discarded during surgery for contusions in adults with traumatic brain injury to see if molecular changes relate to injury progression and recovery.

    Recruiting at 2 sites Mario Negri Institute for Pharmacological Research · Bergamo and 1 other locations · NCT07683169

  • RESOLVIN: Reducing cardiovascular inflammation with fish oil or camelina (plant) oil

    This trial tests whether adding fish oil or camelina (plant) oil to the diet of people over 55 with moderate-to-high cardiovascular risk can lower a lipid-driven inflammation risk score.

    Recruiting at 8 sites Mario Negri Institute for Pharmacological Research · Cortona, Arezzo and 8 other locations · NCT07331103

  • Mild TBI in the Emergency Department

    This study tests how often CT scans are needed for adults with mild brain injury in emergency departments and aims to predict short-term outcomes using existing decision rules and new models.

    Recruiting at 20 sites Mario Negri Institute for Pharmacological Research · Novi Ligure, AL and 58 other locations · NCT07021118

  • Reproducibility of multiparametric kidney MRI on 1.5T scanners

    This project will test how consistently multiparametric kidney MRI measurements can be obtained on common 1.5T MRI scanners in healthy adults aged 18–70.

    Recruiting Mario Negri Institute for Pharmacological Research · Aarhus and 3 other locations · NCT06884410

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.